WuXi Biologics
WuXi Biologics
Bora’s Bold Move: Investing in Tanvex Biomanufacturing!
Bora Pharmaceuticals invests in Tanvex! 🤝 Together, they enhance global biomanufacturing services, boosting biologics capabilities. 🌟🚀 Exciting times ahead! 🌐
Rentschler Biopharma Doubles Production Capacity Making History
🏢 Rentschler Biopharma doubles cGMP capacity with new US production line, aiming to expand in complex biologics market. 🌍📈💰
Revolutionary Supor Prime Filters: The Ultimate Solution for High-Concentration Therapies
🔍 Discover Supor Prime Filters: a reliable filtration solution for high-concentration therapies, ensuring safe and effective manufacturing processes. 🌡️💧🔬💪🏥
Revolutionizing Oral Biologic Delivery: Tiny VHH Antibodies
🔍 Discover how VHH antibodies could revolutionize oral delivery of biologics, overcoming challenges for better absorption and stability.
WuXi Biologics Supercharges Manufacturing with 5000L Bioreactors!
⚡ WuXi Biologics upgrades manufacturing capability with installation of three 5,000L single-use bioreactors! 🏭✨🔝
Revolutionary Model Predicts Biologic Processing Variations
🔍 Scientists have developed a mathematical model to predict RTD in continuous manufacturing of biologics. 🔬🔬🧪💯🔬
Stocks of Chinese Biotechs Plummet as Congress Targets National Security
📰 Chinese biotech giants WuXi AppTec and WuXi Biologics face stock plunge as US Congress targets national security. 📉🔒
